Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2016 1
2017 1
2018 2
2019 1
2022 1
2023 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of Alport syndrome: beyond animal models.
Gross O, Kashtan CE. Gross O, et al. Kidney Int. 2009 Sep;76(6):599-603. doi: 10.1038/ki.2009.223. Epub 2009 Jun 17. Kidney Int. 2009. PMID: 19536083 Free article. Review.
Alport syndrome (AS) is a hereditary glomerulopathy due to abnormal composition of the glomerular basement membrane, leading to end-stage renal disease (ESRD). Studies of animal models of AS have suggested a variety of potentially effective therapies, …
Alport syndrome (AS) is a hereditary glomerulopathy due to abnormal composition of the glomerular basement membrane, le …
RAAS inhibition and the course of Alport syndrome.
Savva I, Pierides A, Deltas C. Savva I, et al. Pharmacol Res. 2016 May;107:205-210. doi: 10.1016/j.phrs.2016.03.017. Epub 2016 Mar 16. Pharmacol Res. 2016. PMID: 26995302 Review.
Alport syndrome (AS) is a hereditary progressive glomerulonephritis with a high life-time risk for end-stage renal disease (ESRD). ...Angiotensin converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) …
Alport syndrome (AS) is a hereditary progressive glomerulonephritis with a high life-time risk for end-stage renal dise …
A review of clinical characteristics and genetic backgrounds in Alport syndrome.
Nozu K, Nakanishi K, Abe Y, Udagawa T, Okada S, Okamoto T, Kaito H, Kanemoto K, Kobayashi A, Tanaka E, Tanaka K, Hama T, Fujimaru R, Miwa S, Yamamura T, Yamamura N, Horinouchi T, Minamikawa S, Nagata M, Iijima K. Nozu K, et al. Clin Exp Nephrol. 2019 Feb;23(2):158-168. doi: 10.1007/s10157-018-1629-4. Epub 2018 Aug 20. Clin Exp Nephrol. 2019. PMID: 30128941 Free PMC article. Review.
Alport syndrome (AS) is a progressive hereditary renal disease that is characterized by sensorineural hearing loss and ocular abnormalities. ...Angiotensin-converting enzyme inhibitors can remarkably delay the development of …
Alport syndrome (AS) is a progressive hereditary renal disease that is characterized by sensorineural hearing loss and …
Effectiveness of renin-angiotensin-aldosterone system blockers in patients with Alport syndrome: a systematic review and meta-analysis.
Zeng M, Di H, Liang J, Liu Z. Zeng M, et al. Nephrol Dial Transplant. 2023 Oct 31;38(11):2485-2493. doi: 10.1093/ndt/gfad105. Nephrol Dial Transplant. 2023. PMID: 37218713 Free article.
BACKGROUND: Although renin-angiotensin-aldosterone system (RAAS) blockers have been considered the primary treatment for patients with Alport syndrome (AS) for a decade, there is no comprehensive review with evidence-based analysis evaluating the effectivenes …
BACKGROUND: Although renin-angiotensin-aldosterone system (RAAS) blockers have been considered the primary treatment for patients wit …
Renal, auricular, and ocular outcomes of Alport syndrome and their current management.
Zhang Y, Ding J. Zhang Y, et al. Pediatr Nephrol. 2018 Aug;33(8):1309-1316. doi: 10.1007/s00467-017-3784-3. Epub 2017 Sep 1. Pediatr Nephrol. 2018. PMID: 28864840
Alport syndrome is a hereditary glomerular basement membrane disease caused by mutations in the COL4A3/4/5 genes encoding the type IV collagen alpha 3-5 chains. Most cases of Alport syndrome are inherited as X-linked dominant, and some as autoso …
Alport syndrome is a hereditary glomerular basement membrane disease caused by mutations in the COL4A3/4/5 genes encodi …
Lifelong effect of therapy in young patients with the COL4A5 Alport missense variant p.(Gly624Asp): a prospective cohort study.
Boeckhaus J, Hoefele J, Riedhammer KM, Nagel M, Beck BB, Choi M, Gollasch M, Bergmann C, Sonntag JE, Troesch V, Stock J, Gross O. Boeckhaus J, et al. Nephrol Dial Transplant. 2022 Nov 23;37(12):2496-2504. doi: 10.1093/ndt/gfac006. Nephrol Dial Transplant. 2022. PMID: 35022790 Free article.
BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEis) have evolved as a first-line therapy for delaying end-stage renal failure (ESRF) in Alport syndrome (AS). ...CONCLUSIONS: For the first time, this study shows that in AS, …
BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEis) have evolved as a first-line therapy for delaying e …